Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Date of authorisation: 15/04/2026, Revision: 1, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 June 2026 - 13:38

Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Date of authorisation: 15/04/2026, Revision: 1, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/enflonsia

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters